# Intersect Systems, Inc.

- Location (FDA's records): Longview, WA
- FDA decisions: 21 (1983–2002): 21 510(k) clearances
- Product codes: CIG (2), DPS (2), KHS (2), CHH (1), LBR (1), CGA (1), CDT (1), JPZ (1), CGS (1), LPS (1), CJW (1), CGX (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K021636: Albumin Reagent (Jul 17, 2002)
- K011972: Direct Bilirubin Reagent (Aug 27, 2001)
- K011692: Homogeneous Enzymic Homocysteine Reagent (Jul 25, 2001)
- K003892: Total Bilirubin Reagent (Feb 20, 2001)
- K983937: Dual Vial Creatinine Reagent (Jan 6, 1999)
- K974833: CK-Nac Reagent (Feb 13, 1998)
- K941807: Intersect Systems' Non-Mercuric Chloride Reagent (Sep 14, 1994)
- K932888: Intersect Systems Direct Amylase Reagent (Jan 31, 1994)

Source page: https://510kreport.com/company/intersect-systems